ReviewCurrent atherosclerosis reports2009
Metabolic syndrome: perception or reality?
Review in Current atherosclerosis reports, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Article
- Correlation Between Anthropometric Measurements and Non-alcoholic Fatty Liver Disease in Individuals With Obesity Undergoing Bariatric Surgery: Cross-Sectional Study.Obesity surgery · 2021Article
- Emerging issues for our nation's health: the intersection of marijuana use and cardiometabolic disease risk.Journal of addictive diseases · 2014Review
- Vascular disease and dementias: paradigm shifts to drive research in new directions.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2013Review
- Subclinical vascular disease and cerebral glutamate elevation in metabolic syndrome.Metabolic brain disease · 2012Article
- Weight loss and low-intensity exercise for the treatment of metabolic syndrome in obese postmenopausal women.The journals of gerontology. Series A, Biological sciences and medical sciences · 2011Article
- Microarray evidences the role of pathologic adipose tissue in insulin resistance and their clinical implications.Journal of obesity · 2011Article
- Elevated cerebral glutamate and myo-inositol levels in cognitively normal middle-aged adults with metabolic syndrome.Metabolic brain disease · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metabolic syndrome is associated with increased risk for type 2 diabetes and cardiovascular disease. It has garnered considerable clinical and research interest as a potential target to reduce cardiovascular risk in addition to the classical risk factors. Whether it exists as a distinct clinical entity has become a subject of controversy and debate. This review appraises the evidence in support of or against recognizing metabolic syndrome as a clinical condition that requires therapeutic intervention. Proper evaluation of cardiovascular disease risk should start with consideration of traditional risk factors using validated tools, such as the short-term 10-year Framingham risk score. Individuals with abdominal obesity should be further assessed for associated cardiometabolic risks. Global cardiovascular disease risk should take into consideration not only short-term but also lifetime risks.
Indexed as
Identifiers
19500489What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.